Battling Advanced Ovarian Cancer: A 64-Year-Old’s Path to Targeted Maintenance
Discover how a 64-year-old patient with advanced, BRCA1/2 wild-type ovarian cancer overcame recurrence through surgical debulking, platinum re-challenge, and targeted rucaparib maintenance therapy.
Battling Advanced Ovarian Cancer: A 64-Year-Old’s Path to Targeted Maintenance Read More »










